Health TrialsbyHealthPanel

CIED Implantation Technique at Assiut University Heart Hospital in Relation to ESC Guidelines

ConditionsCIED-related InfectionsCIED Implantation
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorAssiut University

About this trial

This prospective observational cohort study will evaluate the extent to which cardiac implantable electronic device (CIED) implantation techniques at Assiut University Heart Hospital (AUHH) align with the evidence-based recommendations of the European Society of Cardiology (ESC).

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

All addult patients (≥18 years) referred foran indicatedCIED implantation at Assiut University Heart Hospital

Disqualifiers

Previous implantation of CIED implantation

General contraindications of CIED

Patient refusal

Trial population

Study will involve adult patients (≥18 years) receiving CIED for standard arrhythmic, conduction system diseases or heart failure indications over a period of two years,

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • CIEDimplantation

    Device

    Compare current procedural CIED practice at AUHH to recent ESC guidelines.

Treatment groups

No treatment groups listed

Trial outcomes

Primary outcomes

1

Incidence of procedure-related early complications (composite)

Percentage of patients who develop any of the following within 30 days after pacemaker implantation: hematoma requiring intervention, lead dislodgement requiring reintervention, pneumothorax requiring treatment, pocket or device-related infection requiring antibiotics or device removal, acute pacing failure or sensing abnormality requiring reintervention

Time frame
30 day

Secondary outcomes

1

Incidence of late complications after pacemaker implantation

Number and percentage of patients who develop late device-related complications such as pocket erosion, late infection, venous thrombosis, or lead malfunction after 30 days and up to 12 months post-implantation.

Time frame
12 month

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Assiut University

Lead sponsor

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: